Foundation Medicine Announces 2016 Third Quarter Results and Recent Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Foundation Medicine Announces 2016 Third Quarter Results and Recent Highlights

Genentech (RHHBY) to Make 60+ Presentations at ASH 2016; Will Include Phase III GALLIUM Study Data

November 3, 2016 12:39 PM EDT

Genentech, a member of the Roche Group (OTC: RHHBY), announced that more than 60 abstracts featuring nine of its approved or investigational medicines will be presented during the 58th American Society of Hematology (ASH) Annual Meeting from December 3-6 in San Diego. The abstracts include more than 20 oral presentations across a broad range of medicines and combinations.

The breadth of data we are presenting at ASH this year reflects our deep commitment to people with blood diseases, said Sandra Horning, M.D., chief medical officer and head of Global Product Development. We are... More

Benchmark Downgrades Foundation Medicine (FMI) to Hold

November 3, 2016 7:35 AM EDT

Benchmark downgraded Foundation Medicine (NASDAQ: FMI) from Buy to Hold.

For an analyst ratings summary and ratings history on Foundation Medicine click here. For more ratings news on Foundation Medicine click here.

Shares of Foundation Medicine closed at $21.40 yesterday.

... More